Concept information
Terme préférentiel
Mitolactol
Type
-
mesh:Descriptor
Définition
- Alkylating antineoplastic toxic to bone marrow; used in breast cancer, also in combination with other drugs.
Concept générique
Synonyme(s)
- 10318-26-0 (Mitolactol)
- Dibromodulcitol
- Galactitol, 1,6-dibromo-1,6-dideoxy-
- LJ2P1SIK8Y
Qualificatif(s) autorisé(s)
- administration & dosage (Qualifier)
- adverse effects (Qualifier)
- agonists (Qualifier)
- analogs & derivatives (Qualifier)
- analysis (Qualifier)
- antagonists & inhibitors (Qualifier)
- blood (Qualifier)
- cerebrospinal fluid (Qualifier)
- chemical synthesis (Qualifier)
- chemistry (Qualifier)
- classification (Qualifier)
- economics (Qualifier)
- history (Qualifier)
- immunology (Qualifier)
- isolation & purification (Qualifier)
- metabolism (Qualifier)
- pharmacokinetics (Qualifier)
- pharmacology (Qualifier)
- poisoning (Qualifier)
- radiation effects (Qualifier)
- standards (Qualifier)
- supply & distribution (Qualifier)
- therapeutic use (Qualifier)
- toxicity (Qualifier)
- urine (Qualifier)
Action(s) pharmacologique(s)
Traductions
-
français
-
10318-26-0 (Mitolactol)
-
Dibromodulcitol
-
Galactitol, 1,6-dibromo-1,6-dideoxy-
-
LJ2P1SIK8Y
URI
http://data.loterre.fr/ark:/67375/JVR-L7CZ0D48-H
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}